Quality of life in cutaneous T cell lymphoma patients treated with the anti-CCR4 monoclonal antibody mogamulizumab versus vorinostat: Results from MAVORIC. (September 2018) - Porcu, Pierluigi; Hudgens, Stacie; Quaglino, Pietro; Cowan, Richard; Floden, Lysbeth; Tsianakas, Athanasios; Leoni, Mollie; Dale, Stephen; Duvic, Madeline